Ru Wei
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 2
- Computational Theory and Mathematics top 0.2%
- Molecular Biology top 1%
- Metabolomics and Mass Spectrometry Studies 4
- Metabolism, Diabetes, and Cancer 2
- Epigenetics and DNA Methylation 2
- Transplantation top 2%
- Immunology top 2%
- T-cell and B-cell Immunology 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
-
- Analytical Chemistry and Chromatography 2
-
- Alzheimer's disease research and treatments 2
- Co-authors
- Robert E. GersztenStuart L. SchreiberHeather R. ChristofkLewis C. CantleyMark D. FlemingMarian H. HarrisMatthew G. Vander HeidenArvind Ramanathan
- Journals
- Proceedings of the National Academy of Sciences (2 papers)iScience (1 paper)Cellular and Molecular Neurobiology (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Ru Wei
25 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 2.0k
- Computational Theory and Mathematics 1.2k
- Molecular Biology 5.1k
- Transplantation 151
- Immunology 1.2k
Countries citing papers authored by Ru Wei
This map shows the geographic impact of Ru Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Wei more than expected).
Fields of papers citing papers by Ru Wei
This network shows the impact of papers produced by Ru Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Wei. The network helps show where Ru Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ru Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 12 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 53 | |
| 9 | 2016 | 13 | |
| 10 | 2014 | 11 | |
| 11 | 2011 | 32 | |
| 12 | 2011 | 57 | |
| 13 | 2011 | 66 | |
| 14 | The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthbreakdown → | 2008 | 2244 |
| 15 | 2008 | 313 | |
| 16 | The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Diseasebreakdown → | 2006 | 3714 |
| 17 | Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing. | 1996 | 17 |
| 18 | 1993 | 420 | |
| 19 | 1992 | 464 | |
| 20 | 1988 | 41 |
About Ru Wei
Ru Wei is a scholar working on Neurology, Immunology and Allergy and Immunology, having authored 26 papers that have together received 7.7k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), T-cell and B-cell Immunology (3 papers), Analytical Chemistry and Chromatography (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Alzheimer's disease research and treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (2.0k citations), Computational Theory and Mathematics (1.2k citations) and Molecular Biology (5.1k citations). Ru Wei has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Robert E. Gerszten, Stuart L. Schreiber, Heather R. Christofk, Lewis C. Cantley, Mark D. Fleming, Marian H. Harris, Matthew G. Vander Heiden, Arvind Ramanathan, Steven A. Carr and Eric S. Lander. Their work appears in journals such as Proceedings of the National Academy of Sciences, iScience, Cellular and Molecular Neurobiology, Current Drug Metabolism and Journal of Proteome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.